Ohsu Knight Cancer Institute

This early-phase study tests whether giving two drugs—ruxolitinib and azacitidine—after a stem cell transplant can safely prevent graft-versus-host disease (GVHD) and keep acute myeloid leukemia (AML) from coming back. About 40 adults with AML in remission will receive ruxolitini…

This study tests a new treatment for people with advanced liver cancer that cannot be surgically removed. The treatment combines a type of internal radiation (Y-90) with two immunotherapy drugs (durvalumab and tremelimumab) and a targeted therapy pill (zanzalintinib). The goal is…

This early-phase study tests a surgery that removes the entire pancreas and then transplants the patient's own insulin-making cells into the liver. The goal is to treat chronic pancreatitis and benign tumors while reducing the risk of diabetes. The study includes 12 adults with a…

This Phase 2 trial tests whether a single dose of gruticibart, a monoclonal antibody, can prevent blood clots that often form when a central venous catheter is placed. About 90 adults getting a catheter will receive either the drug or a placebo. The goal is to see if gruticibart …

This trial tests whether a one-on-one peer support program is feasible for people with head and neck cancer. Patients (mentees) are matched with cancer survivors (mentors) for emotional and informational support. The study will enroll 56 participants and measure how many actually…

This study tests whether having melanoma patients regularly report their symptoms through an electronic tool, combined with quick access to specialist care, can improve the management of side effects from immune checkpoint inhibitors. These drugs can cause immune-related side eff…

This study tests whether live, online group strength training can help older cancer survivors (age 65+) who have trouble with daily activities. 150 participants will be split into three groups: immediate strength training, delayed strength training, or stretching. The goal is to …

This phase II trial tests whether taking ulipristal acetate before a mammogram can temporarily reduce breast density in premenopausal people with extremely dense breast tissue. Dense tissue can hide cancers on mammograms, so lowering density may improve screening accuracy. The st…

This pilot trial tests whether a supervised, group exercise program called Exercise Together is safe and feasible for people with primary brain tumors and their caregivers. The program uses resistance training to strengthen muscles used in daily activities and is designed to fost…